The many abilities of omalizumab and the unbeaten path

J Allergy Clin Immunol. 2019 Jun;143(6):2335-2336. doi: 10.1016/j.jaci.2019.02.035. Epub 2019 Apr 20.

Authors

Cristoforo Incorvaia¹, Gian G Riario-Sforza², Erminia Ridolo³

Affiliations

¹ Cardiac/Pulmonary Rehabilitation Unit, ASST Pini-CTO, Milan, Italy. Electronic address: cristoforo.incorvaia@gmail.com.
² Division of Internal Medicine, Sesto San Giovanni Hospital, Milan, Italy.
³ Allergy and Clinical Immunology, Medicine and Surgery Department, University of Parma, Parma, Italy.

PMID: 31014898
DOI: 10.1016/j.jaci.2019.02.035

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Allergic Agents*
Humans
Omalizumab
Urticaria*

Substances

Anti-Allergic Agents
Omalizumab